Navigation Links
Quest Diagnostics Sponsors American Cancer Society's Choose You® Movement
Date:5/9/2011

MADISON, N.J., May 9, 2011 /PRNewswire/ -- Quest Diagnostics, the world's leading provider of diagnostic testing, information and services (NYSE: DGX), today announced its national sponsorship of Choose You®, the American Cancer Society's movement that inspires women to stay well by putting their health first and making healthy lifestyle choices to help prevent cancer. According to the American Cancer Society, 1 in 3 American women will get cancer in her lifetime, but there are steps women can take today to help change that statistic. More than half of cancer deaths could be prevented with healthy lifestyle choices, like maintaining a healthy weight through diet and regular exercise, avoiding tobacco products and getting regular cancer screening tests.

"We look forward to working with Quest Diagnostics as a national sponsor of the Choose You 'get regular health checks' commitment," said Terry Music, chief mission delivery officer for the American Cancer Society. "Their support will go a long way in helping women put their health first."

As part of the movement, women are encouraged to sign a Choose You Commitment, an online pledge to reach a specific, individual health goal. At ChooseYou.com, women can choose from five different health categories: eat right; get active; get regular health checks; protect your skin; and quit smoking. Quest Diagnostics is the national sponsor of the Choose You effort to remind women to 'get regular health checks.'

"Quest Diagnostics is proud to be a national sponsor of this important public health initiative," said Laure Park, Vice President, Corporate Communications and Investor Relations and the company's Corporate Citizenship Officer. "We hope that many will join us in supporting the Choose You movement, in recognizing women everywhere who care for their families, and in reminding them to also care for themselves."

Jon R. Cohen, M.D., Quest Diagnostics Senior Vice President and Chief Medical Officer said, "Our work at Quest Diagnostics is to put patients first every day. In doing so, we witness firsthand how prevention and early detection can change a life. By inspiring women to see their doctors and get their regular health checks, the American Cancer Society and its Choose You movement have the power to make a difference in American health – and for American families."

Quest Diagnostics is the world's leader in cancer diagnostics and is nationally recognized for its commitment to the health and wellness of its employees. In 2010, the company earned Cancer Gold Standard accreditation from the CEO Roundtable on Cancer in recognition of its commitment to its employees through the cancer continuum, from prevention and early detection to diagnosis, treatment and care. Quest Diagnostics Chairman, CEO and President Surya N. Mohapatra is an inaugural member of the American Cancer Society's CEOs Against Cancer® New Jersey Chapter, and the company is a 2010 Platinum Employer for Healthy Lifestyles award recipient from the National Business Group on Health for its HealthyQuest employee wellness program.

To learn more, visit QuestDiagnostics.com/ChooseYou.

About Quest Diagnostics

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: www.questdiagnostics.com.

Contacts: Barb Short, Media, 973-520-2800; Kathleen Valentine, Investors, 973-520-2900


'/>"/>
SOURCE Quest Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
2. VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
3. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
4. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
5. VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
6. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
7. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
8. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
9. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
10. BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
11. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 11, 2016  AfterPill.com is reporting that this week,s ... for all women who are at risk of unintended ... year and raises the risks of unprotected sex in ... According to the Guttmacher Institute, there are 43 ... child-bearing age, who have sex without the intention of ...
(Date:2/11/2016)... de fevereiro de 2016  A Proliant Biologicals ... de soroalbumina bovina (BSA -- Bovine Serum ... na Ilha Norte da Nova Zelândia, em Feilding. ... na fábrica da Proliant nos EUA, localizada em ... e instalação dos equipamentos foram feitos de forma ...
(Date:2/11/2016)... MEADOWS , Ill. and INDIANAPOLIS , ... milestone for many young people, but for those with ... Not only do these students juggle class schedules, assignments ... of living with type 1 diabetes. On top of ... first time. Diabetes Scholars Foundation (Foundation) ...
Breaking Medicine Technology:
(Date:2/11/2016)... Alpharetta, Georgia (PRWEB) , ... February 11, 2016 ... ... Physicians Group (DMPG) will use the action analytics leader’s population health solutions, ... analytics and clinical support to the Atlanta-area healthcare system. Details of the contract ...
(Date:2/11/2016)... ... February 11, 2016 , ... Dr. Sadati’s ... of cosmetic procedures. Along with performing procedures, the magazine also highlights that Dr. ... cosmetic procedures. One of the most common procedures he performs is his natural ...
(Date:2/11/2016)... ... 2016 , ... Image One USA veteran franchise owner Maria Bogacki ... buildings of Nashville that will benefit. , “I’ve enjoyed being a part of the ... was no question that I would bring my business with me,” Bogacki said. “The ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... to reverse diabetes has been gearing up for their simultaneous grand openings in ... It’s about right now that you’re probably wondering, is reversing diabetes possible? According ...
(Date:2/11/2016)... ... February 11, 2016 , ... In a new paper ... surgeon , Dr. Rod J. Rohrich, and colleagues, examine and underscore the importance ... for rhinoplasty surgeons when addressing this vital area. , The upper lateral cartilage ...
Breaking Medicine News(10 mins):